Royal Unibrew H1 2025 slides: EBIT up 11%, company narrows full-year guidance

Royal Unibrew A/S reported robust H1 2025 results, with EBIT up 11% (9% organic) and margin expanding 80 basis points to 12.5%, alongside an 18% increase in net profit, signaling a strong recovery from Q1 underperformance. This resilience stemmed from effective geographic diversification, with strong performances in Western Europe and International segments offsetting weather-related challenges in Northern Europe. The company initiated a DKK 300 million share buy-back and narrowed its full-year 2025 guidance for net revenue growth to 5-6% and EBIT growth to 8-12%, reflecting increased certainty and operational efficiency despite a stable yet challenging consumer environment.

Analysis

Royal Unibrew A/S (CPH:RBREW) demonstrated significant operational resilience and strategic execution in its H1 2025 results, marking a strong recovery from a disappointing first quarter. The company reported an 11% increase in EBIT and an 18% rise in net profit, driven by an 80 basis point expansion in EBIT margin to 12.5%. This performance underscores the success of its geographic diversification strategy, as exceptional results in Western Europe (EBIT +33%) and International (EBIT +55%) segments more than compensated for weather-related headwinds in Northern Europe, where revenue declined 3%. Management's focus on efficiency is evident in the controlled 2% increase in the cost base, which fueled margin growth despite a challenging consumer environment. The initiation of a DKK 300 million share buy-back program signals confidence, while the narrowed full-year guidance for EBIT growth to 8-12% reflects increased certainty rather than a significant downgrade. While free cash flow decreased to DKK 458 million due to planned capital expenditures, the company's leverage remains stable with a NIBD/EBITDA ratio of 2.3x, aligning with its strategic targets.

Key Decisions for Investors

• Given the strong H1 fundamental performance and margin expansion, investors may view the recent stock price decline from its 52-week high as a potential valuation dislocation, warranting a reassessment of the company's current market price.
• Monitor the performance of the Western Europe and International segments, as their continued high-growth momentum is critical to validating the company's diversification strategy and offsetting volatility in the mature Northern Europe market.
• The DKK 300 million share buy-back should be viewed as a strong signal of management's confidence, while the narrowed guidance reflects operational control and should be weighed against stated headwinds from foreign exchange and reduced private label activity.
• Investors should track progress on strategic initiatives, particularly the integration of new activities in BeNeLux and Norway, as their successful execution to meet the 10% cash ROIC target by 2026 is a key catalyst for future value creation.